Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $28.2400 (-2.35%) ($28.1000 - $28.9000) on Tue. Jul. 21, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.59% (three month average) | RSI | 61 | Latest Price | $28.2400(-2.35%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.1% a day on average for past five trading days. | Weekly Trend | HALO advances 1.7% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(51%) IBB(50%) IWM(47%) IWC(45%) ARKG(43%) | Factors Impacting HALO price | HALO will decline at least -1.295% in a week (0% probabilities). VIXM(-31%) UUP(-15%) VXX(-14%) TLT(-2%) IYT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.295% (StdDev 2.59%) | Hourly BBV | 0 () | Intraday Trend | -2.3% | | | |
|
5 Day Moving Average | $28.64(-1.4%) | 10 Day Moving Average | $28.32(-0.28%) | 20 Day Moving Average | $27.48(2.77%) | To recent high | -2.8% | To recent low | 43.8% | Market Cap | $3.86b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |